Anita S Kablinger Selected Research

Anita S Kablinger Research Topics

3	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 09/2012
2	Major Depressive Disorder (Major Depressive Disorders) 03/2024 - 01/2023
2	Mood Disorders (Mood Disorder) 01/2023 - 01/2023
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 04/2004
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Weight Loss (Weight Reduction) 11/2023
1	Alcoholism (Alcohol Abuse) 11/2023
1	Obesity 11/2023
1	Binge Drinking 11/2023
1	Anxiety Disorders (Anxiety Disorder) 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Hallucinations (Hallucination) 01/2023
1	Paranoid Disorders (Paranoia) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Paraphilic Disorders (Paraphilia) 01/2013
1	Serotonin Syndrome (Syndrome, Serotonin) 01/2012
1	Fibromyalgia (Fibrositis) 11/2005

3	Buprenorphine (Subutex)FDA LinkGeneric 01/2022 - 09/2012
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2023 - 04/2004
2	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 11/2005
1	EsketamineIBA 03/2024
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	semaglutideIBA 11/2023
1	Peptides (Polypeptides)IBA 11/2023
1	tirzepatideIBA 11/2023
1	Hypnotics and Sedatives (Sedatives)IBA 11/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2023
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2023
1	Olanzapine (Zyprexa)FDA Link 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Antidepressive Agents (Antidepressants)IBA 01/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023
1	Phencyclidine (Angel Dust)IBA 01/2023
1	Naloxone Drug Combination Buprenorphine FDA Link 01/2022
1	Naloxone (Narcan)FDA LinkGeneric 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2013
1	NyquilIBA 01/2012
1	Sertraline (Zoloft)FDA LinkGeneric 01/2012
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 01/2012
1	Pindolol (LB 46)FDA LinkGeneric 11/2005
1	AutoreceptorsIBA 11/2005
1	beta Adrenergic ReceptorsIBA 11/2005

1	Transcranial Magnetic Stimulation 03/2024